Bristol-Myers Squibb Company (BMV:BMY)

Mexico flag Mexico · Delayed Price · Currency is MXN
1,051.00
+17.00 (1.64%)
At close: Feb 9, 2026
Market Cap2.13T -13.1%
Revenue (ttm)867.65B -0.2%
Net Income126.99B
EPS62.29
Shares Outn/a
PE Ratio16.74
Forward PE9.68
Dividend46.81 (4.45%)
Ex-Dividend DateJan 2, 2026
Volume50
Average Volume4,706
Open1,051.00
Previous Close1,034.00
Day's Range1,051.00 - 1,051.00
52-Week Range789.00 - 1,261.00
Beta0.30
RSI69.93
Earnings DateFeb 5, 2026

About BMV:BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange Mexican Stock Exchange
Ticker Symbol BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements